Cargando…

Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study

BACKGROUND: The Taiwan Health Insurance Bureau has conducted a bundled payment system for hemodialysis reimbursement since 1995. The maximum dose of erythropoiesis‐stimulating agents allowed by insurance is capped at 20 000 U of epoetin or 100 μg of darbepoetin alfa per month. Nephrologists have avo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Ko‐Lin, Hung, Szu‐Chun, Tseng, Wei‐Cheng, Tsai, Ming‐Tsun, Liu, Jia‐Sin, Lin, Ming‐Huang, Hsu, Chih‐Cheng, Tarng, Der‐Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201445/ https://www.ncbi.nlm.nih.gov/pubmed/30371224 http://dx.doi.org/10.1161/JAHA.118.009206

Ejemplares similares

Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study
por: Kuo, Ko-Lin, et al.
Publicado: (2022)

Comparison of Simplified Creatinine Index and Systemic Inflammatory Markers for Nutritional Evaluation of Hemodialysis Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2021)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

Relationship between Circulating Galectin-3, Systemic Inflammation, and Protein-Energy Wasting in Chronic Hemodialysis Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2021)

AN69 Filter Membranes with High Ultrafiltration Rates during Continuous Venovenous Hemofiltration Reduce Mortality in Patients with Sepsis-Induced Multiorgan Dysfunction Syndrome
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation
por: Tseng, Wei-Cheng, et al.
Publicado: (2020)

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2012)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Artificial Intelligence for Risk Prediction of Rehospitalization with Acute Kidney Injury in Sepsis Survivors
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Artificial Intelligence for Risk Prediction of End-Stage Renal Disease in Sepsis Survivors with Chronic Kidney Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2022)

High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients
por: Hsu, Wei-Liang, et al.
Publicado: (2017)

Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2015)

Beyond a Measure of Liver Function—Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2018)

Aldosterone and Mortality in Hemodialysis Patients: Role of Volume Overload
por: Hung, Szu-Chun, et al.
Publicado: (2013)

Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
por: Chen, Yu-Hsin, et al.
Publicado: (2015)

Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study
por: Chu, Kuo-An, et al.
Publicado: (2019)

Echocardiographic features of left ventricular dysfunction and outcomes in chronic kidney disease
por: Ou, Shuo-Ming, et al.
Publicado: (2023)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

UMOD Mutations in Chronic Kidney Disease in Taiwan
por: Chen, Huan-Da, et al.
Publicado: (2022)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

A double-blind, randomized, and active-controlled phase III study of Herbiron drink in the treatment of iron-deficiency anemia in premenopausal females in Taiwan
por: Lee, Ching-Tzu, et al.
Publicado: (2016)

Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial
por: Lee, Chien-Te, et al.
Publicado: (2022)

Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
por: Ou, Shuo-Ming, et al.
Publicado: (2021)

Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade
por: Lin, Chih-Ching, et al.
Publicado: (2017)

The Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Benefits of Stem Cells in Acute Ischemic Kidney Injury
por: Lee, Kuo-Hua, et al.
Publicado: (2019)

Hemodialysis vascular access care during the COVID-19 pandemic
por: Yang, Chih-Yu, et al.
Publicado: (2020)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms
por: Ou, Shuo-Ming, et al.
Publicado: (2023)

Vitamin C and functional iron deficiency anemia in hemodialysis()
por: Kim, Yong-Lim
Publicado: (2012)

Risks and outcomes of critical limb ischemia in hemodialysis patients: a prospective cohort study
por: Hsieh, Mu-Yang, et al.
Publicado: (2022)

Fatal events on chronic hemodialysis (HD) in Croatia
por: Gasparovic, V, et al.
Publicado: (2002)

Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
por: Tseng, Wei-Cheng, et al.
Publicado: (2021)

Adaptation and Validation of Alternative Healthy Eating Index in Hemodialysis Patients (AHEI-HD) and Its Association with all-Cause Mortality: A Multi-Center Follow-Up Study
por: Van Duong, Tuyen, et al.
Publicado: (2019)

Hyperuricemia Predicts an Early Decline in Renal Function among Older People: A Community-Based Cohort Study
por: Tseng, Wei-Cheng, et al.
Publicado: (2019)

Stent grafts improved patency of ruptured hemodialysis vascular accesses
por: Liao, Min-Tsun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4080o3f11herra259b8dnk9f1